• 1
    Boscarino J.A., Rukstalis M., Hoffman S. N., Han J. J., Erlich P. M., Gerhard G. S. et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US healthcare system. Addiction 2010; 105: 177682.
  • 2
    Boudreau D., Von Korff M., Rutter C. M., Saunders K., Ray G. T., Sullivan M. D. et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009; 18: 116675.
  • 3
    Noble M., Treadwell J. R., Tregear S. J., Coates V. H., Wiffen P. J. Akafomo C. et al. Long-term opioid management for chronic non-cancer pain. Cochrane Database Syst Rev 2010; Issue 1. Art no.: CD006605. DOI: 10.1002/14651858.CD006605.pub2 [Review content assessed as up-to-date, 18 May, 2009. John Wiley & Sons Ltd.
  • 4
    Fishbain D. A., Cole B., Lewis J., Rosomoff H. L., Rosomoff R. S. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008; 9: 44459.
  • 5
    Fleming M. F., Balousek S. L., Klessig C. L., Mundt M. P., Brown D. D. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain 2007; 8: 57382.
  • 6
    Banta-Green C. J., Merrill J. O., Doyle S. R., Boudreau D. M., Calsyn D. A. Opioid use behaviors, mental health and pain—development of a typology of chronic pain patients. Drug Alcohol Depend 2009; 104: 3442.
  • 7
    Sullivan M. D., Von Korff M., Banta-Green C., Merrill J. O., Saunders K. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain 2010; 149: 34553.
  • 8
    Dunn K. M., Saunders K. W., Rutter C. M., Banta-Green C. J., Merrill J. O., Sullivan M. D. et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010; 152: 8592.
  • 9
    Saunders K. W., Dunn K. M., Merrill J. O., Sullivan M. D., Weisner C. M., Braden J. B. et al. Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med 2010; 25: 31015.
  • 10
    Walker J. M., Farney R. J., Rhondeau S. M., Boyle K. M., Valentine K., Cloward T. V. et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med 2007; 3: 45561.
  • 11
    Zhou H. Y., Chen S. R., Chen H., Pan H. L. Opioid-induced long-term potentiation in the spinal cord is a presynaptic event. Neuroscience 2010; 30: 44606.
  • 12
    Tuteja A. K., Biskupiak J., Stoddard G. J., Lipman A. G. Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 2010; 22: 42430.
  • 13
    Vuong C., Van Uum S. H., O'Dell L. E., Lutfy K., Friedman T. C. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010; 31: 98132.
  • 14
    Ballantyne J. C., Mao J. Opioid therapy for chronic pain. N Engl J Med 2003; 349: 194353.